Pooled Analysis Shows Men Have Higher Mortality Than Women
Effect size varies across countries; smoking and cardiovascular disease substantially attenuate effect size
Women Show Faster Cognitive Decline Than Men
Declines in global cognition and executive function significantly faster for women, despite higher baseline performance
ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
Event rates for time to first fatal or nonfatal stroke significantly reduced for IPE versus placebo
Prevalence of Vascular Risk Factors High for Hispanics/Latinos
Despite high awareness, secondary stroke prevention strategies are low
Over Half Have Symptoms of Major Depressive Disorder After COVID-19
Presence of headache and greater overall severity linked to increased odds of moderate or greater depression symptoms
ASA: Retinopathy Linked to Increased Risk for Stroke, Dementia
Dose-dependent relationship seen between severity of retinopathy and all-cause mortality
One in Five Health Care Workers Reports Mental Health Conditions
Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic
CNS-Active Polypharmacy Examined in Seniors With Dementia
Most common medication was gabapentin, which was linked to 33.0 percent of polypharmacy-days
AAN: Fetal Exposure to Antiseizure Meds Has No Neuropsychological Impact
No difference found in primary outcome of Verbal Index score at age 3 years with fetal exposure to ASM or for those born to healthy women
No Effect of Low-Dose Atorvastatin Found for Muscle Symptoms
For participants reporting muscle symptoms when taking statins, no overall effect seen for atorvastatin 20 mg versus placebo
